POTENTIAL THERAPEUTIC EFFECT OF ZIKA VIRUS IN GLIOBLASTOMA TREATMENT
Main Article Content
Abstract
Since the twentieth century, humanity has been experiencing a public health reality marked by numerous mosquito-borne diseases (belonging to the arthropod class), known as arboviruses. The Zika virus has become in recent years a risk to Brazilian and international public health due to its devastating effect due to its pathogenesis but also to fetal neurological development, causing serious health problems such as microcephaly and Guillain-Barré Syndrome, but also myelitis and meningoencephalitis. However, scientists studying the Zika virus have been trying to use the agent's ability to cause infections in healthy cells to attack and destroy cancer cells, such as the case of grade IV astrocytoma known as Gliobastoma Multiforme (GBM), which is a tumor of the very aggressive central nervous system and worse prognosis among primary cancers. As a result of effective therapy for GBM and the tropism of this etiological agent for brain cells, the hypothesis is that this virus would cause cell death in glioblastomas through metabolic alterations induced by the induced viral infection, but further studies must be carried out to demonstrate this therapeutic advantage in using the virus for the treatment of this malignant disease.
Keywords: Zika virus; Gliobastoma Multiforme; Tumor of the Central Nervous System.
Metrics
Article Details
This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
References
Wood H. A new role for Zika virus in glioblastoma therapy? Nat Rev Neurol. 2017 Sep 22.
Xu M, et al. Identification of small-molecule inhibitors of Zikavirus infection and induced neural cell death via a drug repurposing screen. Nat Med. 2016 Aug 29 :1-9.
Gergely F, et al. Neurodevelopmental protein Musashi 1 interacts with the Zika genome and promotes viral replication. Sciense. 2017 Jun 1:1-14.
Carvalho NS, Carvalho BF, Fugaça CA, Doris B, Biscaia ES. Zika virus infection during pregnancy and microcephaly occurrence: a review of literature and Brazilian data. Braz J Infect Dis. 2016 Apr 16;20(3):282–289.
Kaid C, et al. Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells In Vitro and In Vivo. Cancer Res. 2018 Apr 26; 78(12): 3363–74.
Hajj KA, Whitewead KA. Tools for translation: non-viral materials for therapeutic mRNA delivery. Nat Rev. 2017 Sep 12; 2: 1-17.
Lim M, Maxwell R, Luksik AS, Garzon-Muvdi T. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma–Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses. Curr Neurol Neurosci Rep. 2017 May 09; 50: 1-12.
Egan KM, et al. Handedness and the risk of glioma. J Neurooncol. 2018 Jan 13; 1-6.
Opoku-Darko M, Amuah JE, Kelly JJP. Surgical Resection of Anterior and Posterior Butterfly Glioblastoma. World Neurosurg. 2017 1-9.
Gewin Virginia. Tumour tactician. Nature. 2017 Jun 29; 546: 1.
Low W, et al. Zika virus targeting of malignant human and murine brain tumors. Neuro Oncol. 2017; 173 (19 Suppl 6):1.
Zhu Z, et al. Zika virus has oncolytic activity against glioblastoma stem cells. J. Exp. Med. 2017; 214 (10): 2843–2857.
Catharino RR, et al. MALDI-Imaging detects endogenous Digoxin in glioblastoma cells infected by Zika virus – would it be the oncolytic key?. J Mass Spectrom. 2018 Mar; 53(3):257-263.
Baima C. Pesquisadores acreditam que vírus zika pode combater câncer cerebral. 2017. https://oglobo.globo.com/sociedade/saude/pesquisadores-acreditam-que-virus-zika-pode-combater-cancer-cerebral-21787525.
Wakimoto H, et al. Blockade of transforming growth factor-β signaling enhances
oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models. Int J Cancer. 2017 Dec 1;141(11):2348-2358.
Chandramohan V, et al. Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas. Arch Pathol Lab Med. 2017 Feb 28; 141(12):1697-1704.
Bell JC, Llkow CS. A Viro-Immunotherapy Triple Play for the Treatment of Glioblastoma. Cancer Cell. 2017 Aug 14;32(2):133-134.
Lubin JA, Zhang RR, Kuo JS. Zika Virus has Oncolytic Activity Against Glioblastoma Stem Cells. Neurosurgery. 2018 May 1;82(5):E113-E114.